AMX0035

sodium phenylbutyrate and tauroursodeoxycholic acid · Amylyx Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for AMX0035, covering 2021-08-11 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: AMX0035 in Adult Patients With Wolfram Syndrome [Phase 2]